267 related articles for article (PubMed ID: 7010382)
1. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
Nissinen A; Tuomilehto J
Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
[TBL] [Abstract][Full Text] [Related]
2. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
Leonetti G; Pasotti C; Capra A
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
[TBL] [Abstract][Full Text] [Related]
4. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
Salako LA; Falase AO; Aderounmu AF; Walker O
Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
[TBL] [Abstract][Full Text] [Related]
5. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
Fogari R; Zoppi A
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
[TBL] [Abstract][Full Text] [Related]
6. [Results of a multicenter trial of antihypertensive treatment with atenolol, alone or in combination with chlorthalidone, of patients with mild, moderate and severe hypertension].
Novo S; Giannola A; Immordino R; Strano A
Cardiologia; 1987 Jan; 32(1):33-49. PubMed ID: 3555793
[No Abstract] [Full Text] [Related]
7. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
Boike SC; Durley Y; Cubberley RB
Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
[No Abstract] [Full Text] [Related]
8. [Treatment of essential arterial hypertension with the fixed-dose combination of atenolol and chlorthalidone (Tenoretic) in a single daily administration].
Lavezzaro GC; Eandi M; Minelli M; Gastaldo D; Noussan P; Angelino PF; Buraglio M
Minerva Cardioangiol; 1982; 30(7-8):359-66. PubMed ID: 7133425
[No Abstract] [Full Text] [Related]
9. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
[TBL] [Abstract][Full Text] [Related]
11. [Systolic-diastolic function of the left ventricle and flowmetry of the lower limbs in the treatment of moderate essential arterial hypertension with atenolol-chlorthalidone].
Franchi F; Bisi G; Fabbri G; Pedenovi P; Lo Sapio P; Matassi L; Righi D; Galanti G
Minerva Cardioangiol; 1986 Sep; 34(9):567-77. PubMed ID: 3543732
[No Abstract] [Full Text] [Related]
12. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
de Leeuw PW; Notter T; Zilles P
J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the antihypertensive effectiveness of the atenolol-chlorthalidone combination (Tenoretic)].
Malini PL; Costa FV; Cavallini C; Marata AM; Ambrosioni E; Magnani B
Minerva Cardioangiol; 1982; 30(7-8):375-80. PubMed ID: 7133427
[No Abstract] [Full Text] [Related]
14. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
[TBL] [Abstract][Full Text] [Related]
16. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
Curry RC; Schwartz KM; Urban PL
South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
[TBL] [Abstract][Full Text] [Related]
17. Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension.
Maxwell MH; Garrett BN; Saunders E; Schnaper H
Clin Ther; 1987; 9(4):380-9. PubMed ID: 3607820
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
[TBL] [Abstract][Full Text] [Related]
20. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
Kraft K; Schiessl S; Vetter H
Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
